Hester Biosciences Beheer
Beheer criteriumcontroles 3/4
De CEO Hester Biosciences is Rajiv Gandhi, benoemd in Mar2005, heeft een ambtstermijn van 19.67 jaar. De totale jaarlijkse vergoeding van { bedraagt ₹ 37.07M, bestaande uit 51.4% salaris en 48.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 10.47% van de aandelen van het bedrijf, ter waarde ₹ 2.12B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.6 jaar en 4.6 jaar.
Belangrijke informatie
Rajiv Gandhi
Algemeen directeur
₹37.1m
Totale compensatie
Percentage CEO-salaris | 51.4% |
Dienstverband CEO | 19.7yrs |
Eigendom CEO | 10.5% |
Management gemiddelde ambtstermijn | 3.6yrs |
Gemiddelde ambtstermijn bestuur | 4.6yrs |
Recente managementupdates
Hester Biosciences Limited's (NSE:HESTERBIO) CEO Compensation Looks Acceptable To Us And Here's Why
Aug 23Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Jan 11How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?
Aug 07Recent updates
Hester Biosciences Limited's (NSE:HESTERBIO) CEO Compensation Looks Acceptable To Us And Here's Why
Aug 23What Hester Biosciences Limited's (NSE:HESTERBIO) 26% Share Price Gain Is Not Telling You
Jul 27Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price
Jun 12Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00
Aug 01Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?
Mar 03Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?
Feb 13What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?
Jan 26Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Jan 11Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 25Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 10These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Nov 25How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?
Nov 10If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns
Oct 26What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Oct 05Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?
Sep 14These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Aug 25How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?
Aug 07Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?
Jul 07Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹235m |
Jun 30 2024 | n/a | n/a | ₹194m |
Mar 31 2024 | ₹37m | ₹19m | ₹189m |
Dec 31 2023 | n/a | n/a | ₹185m |
Sep 30 2023 | n/a | n/a | ₹257m |
Jun 30 2023 | n/a | n/a | ₹285m |
Mar 31 2023 | ₹41m | ₹19m | ₹266m |
Dec 31 2022 | n/a | n/a | ₹298m |
Sep 30 2022 | n/a | n/a | ₹271m |
Jun 30 2022 | n/a | n/a | ₹308m |
Mar 31 2022 | ₹48m | ₹20m | ₹393m |
Dec 31 2021 | n/a | n/a | ₹413m |
Sep 30 2021 | n/a | n/a | ₹451m |
Jun 30 2021 | n/a | n/a | ₹412m |
Mar 31 2021 | ₹52m | n/a | ₹344m |
Dec 31 2020 | n/a | n/a | ₹275m |
Sep 30 2020 | n/a | n/a | ₹267m |
Jun 30 2020 | n/a | n/a | ₹265m |
Mar 31 2020 | ₹39m | n/a | ₹292m |
Dec 31 2019 | n/a | n/a | ₹396m |
Sep 30 2019 | n/a | n/a | ₹409m |
Jun 30 2019 | n/a | n/a | ₹413m |
Mar 31 2019 | ₹21m | ₹20m | ₹416m |
Mar 31 2018 | ₹24m | ₹19m | ₹256m |
Compensatie versus markt: De totale vergoeding ($USD 439.02K ) Rajiv } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 193.69K ).
Compensatie versus inkomsten: De vergoeding van Rajiv is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Rajiv Gandhi (62 yo)
19.7yrs
Tenure
₹37,070,000
Compensatie
Mr. Rajiv Dinesh Gandhi serves as Independent Director for Steelcast Limited since January 23, 2023. Mr. Gandhi joined the Steelcast Limited on January 23, 2023. He has been the Executive Chief Executive O...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Executive CEO | 19.7yrs | ₹37.07m | 10.47% ₹ 2.1b | |
Executive Director | no data | ₹5.40m | geen gegevens | |
Chief Financial Officer | no data | geen gegevens | geen gegevens | |
Senior VP of Sales & Marketing and COO | less than a year | geen gegevens | geen gegevens | |
Company Secretary & Compliance Officer | 6.5yrs | geen gegevens | geen gegevens | |
CEO of Hester Biosciences Nepal Private Limited | no data | geen gegevens | geen gegevens | |
Consultant | no data | geen gegevens | geen gegevens |
3.6yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van HESTERBIO wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.6 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Executive CEO | 37.6yrs | ₹37.07m | 10.47% ₹ 2.1b | |
Executive Director | 3.1yrs | ₹5.40m | geen gegevens | |
Non-Executive Non-Independent Chairman | 31.9yrs | ₹250.00k | 4.69% ₹ 949.5m | |
Non-Executive & Non-Independent Director | 25.6yrs | geen gegevens | 4.74% ₹ 959.6m | |
Non Executive Non Independent Director | 37.6yrs | ₹270.00k | 8.2% ₹ 1.7b | |
Non-Executive Independent Director | 3.1yrs | ₹150.00k | geen gegevens | |
Alternate Director | 8.5yrs | ₹150.00k | 8.19% ₹ 1.7b | |
Non-Executive Independent Director | 4.6yrs | ₹480.00k | geen gegevens | |
Non-Executive Independent Director | 4.6yrs | ₹500.00k | geen gegevens | |
Non-Executive & Independent Director | 1.4yrs | ₹150.00k | geen gegevens | |
Non-Executive & Independent Director | 1.4yrs | ₹100.00k | geen gegevens |
4.6yrs
Gemiddelde duur
58.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van HESTERBIO wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.6 jaar).